1469P - Circulating tumour DNA (ctDNA) analysis in patients (pts) with non-small cell lung cancer (NSCLC) treated with telisotuzumab vedotin (teliso-v), an antibody-drug conjugate targeting c-Met
- Resource Type
- Abstract
- Source
- In
Annals of Oncology October 2019 30 Supplement 5:v596-v597 - Subject
- Language
- ISSN
- 0923-7534